Skip to main content

Table 3 Prognostic prediction models for the outcomes of patients with locally advanced cervical squamous cell cancer

From: MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy

Prediction Models

Training

Testing

Wald Test

P-value

C-index

Wald Test

P-value

C-index

Progression-free survival

 2018 FIGO staging system

20.83

<0.001

0.657

10.82

0.001

0.677

 Clinical model

33.57

<0.001

0.731

15.94

<0.001

0.725

 Rad-PFS

40.17

<0.001

0.764

13.62

<0.001

0.762

 Combined model

50.67

<0.001

0.792

21.28

<0.001

0.809

Overall survival

 2018 FIGO staging system

12.54

<0.001

0.665

5.54

0.02

0.633

 Clinical model

22.53

<0.001

0.708

5.96

0.01

0.693

 Rad-OS

23.97

<0.001

0.793

12.72

<0.001

0.750

 Combined model

31.59

<0.001

0.822

13.43

<0.001

0.785

  1. PFS progression-free survival, OS overall survival, FIGO Federation of Gynecology and Obstetrics.
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us